Intel Corporation (Form 10-K) — Fiscal 2016
Reporting period: Year ended December 31, 2016; fiscal 2016 included 53 weeks, compared with 52 weeks in fiscal 2015. The filing also reports fourth-quarter results.
Business context
Intel designs and manufactures semiconductor platforms and related products, principally for client computing, data centers, Internet of Things, memory, security, and programmable solutions markets. Management described a strategic shift from a PC-centric company toward cloud and connected-device growth. The Altera acquisition added programmable solutions (PSG); Intel also announced plans to divest Intel Security Group (ISecG).
Financial highlights
| Metric | FY 2016 | FY 2015 | Change |
|---|---|---|---|
| Revenue | $59.387B | $55.355B | Up 7% |
| Gross margin | $36.191B; 60.9% | $34.679B; 62.6% | Margin down 1.7 percentage points |
| Operating income | $12.874B | $14.002B | Down 8% |
| Net income | $10.316B | $11.420B | Down 10% |
| Diluted EPS | $2.12 | $2.33 | Down 9% |
| Operating cash flow | $21.808B | $19.017B | Up $2.791B |
| Capital expenditures | $9.625B | $7.326B | Up $2.299B |
Fourth quarter: Revenue was $16.374B versus $14.914B in Q4 2015; net income was $3.562B versus $3.613B; diluted EPS was $0.73 versus $0.74.
Cash, liquidity, and debt: Cash, cash equivalents, short-term investments, and trading assets totaled $17.099B at year-end, down from $25.313B. Total debt was $25.283B, up from $22.670B; debt was 38.2% of permanent stockholders’ equity. Current assets were $35.508B and current liabilities were $20.302B. Intel reported no commercial paper outstanding and said it expected adequate resources for business needs over the next 12 months. $13.6B of the $17.1B in cash and specified investments was held by non-U.S. subsidiaries; most of that amount was designated indefinitely reinvested abroad.
Capital returns: Intel paid $4.925B in dividends and repurchased $2.587B of stock in 2016. The annual dividend per share was $1.04.
Material changes and segment performance
- Revenue growth reflected Altera/PSG, an extra fiscal week, and growth in Data Center, Client Computing, and IoT. Client Computing revenue rose 2% to $32.908B; Data Center revenue rose 8% to $17.236B; IoT revenue rose 15% to $2.638B.
- Client Computing platform unit sales fell 10%, while average selling prices rose 11%. Data Center platform unit sales rose 8%, while average selling prices declined 1%.
- Non-Volatile Memory Solutions revenue was nearly flat at $2.576B, but the segment moved from $239M operating income to a $544M operating loss, reflecting competitive pricing, 3D NAND ramp costs, and higher 3D XPoint investment.
- Gross margin percentage fell, primarily due to Altera and other acquisition-related charges, weaker memory margins, factory start-up costs (particularly 10nm), and higher warranty and intellectual-property charges. Lower platform unit costs and stronger platform pricing partly offset those pressures.
- Operating income and EPS declined despite higher revenue, reflecting $1.886B of restructuring and other charges, higher spending, and acquisition-related amortization. R&D and marketing, general and administrative expenses together were $21.137B, up 5%.
Outlook, commentary, risks, and unusual items
- Transformation and restructuring: The 2016 program generated $1.823B of charges and was expected to affect approximately 15,000 employees. Intel estimated about $1.6B in annual headcount savings, expected to be fully realized by Q2 2017, with savings redirected toward growth areas. Completion was expected substantially by Q2 2017.
- Acquisition and divestiture: Intel completed the Altera acquisition; 2016 cash used for acquisitions was $15.470B. The planned ISecG transaction valued the transferred business at approximately $4.2B, with consideration of approximately $3.1B and a 49% ownership interest in the new company; closing was expected in Q2 2017.
- Accounting estimate: Extending the estimated useful life of wafer-fabrication machinery and equipment from four to five years increased 2016 operating income by about $1.3B, net income by about $950M, and diluted EPS by about $0.19.
- Product and investment plans: Intel expected next-generation Xeon products and 3D XPoint technology releases in 2017, and continued development of 10nm process technology. The filing does not provide clear numeric full-year 2017 guidance; it points readers to the separate Business Outlook published with the January 2017 earnings release.
- Principal risks: Demand shifts and PC-market weakness, intense competition, pricing and product-mix pressure, manufacturing-transition timing and yields, supply-chain concentration, product defects, cybersecurity and privacy threats, foreign-exchange exposure, and global regulatory or geopolitical disruption. The filing notes that about 78% of 2016 revenue was generated outside the U.S. and that the three largest customers represented 38% of revenue.
- Legal and contingency matters: Intel disclosed competition, shareholder, and other litigation. The European Commission’s €1.1B competition fine had been paid; Intel’s appeal remained pending, with a court decision expected in the first half of 2017. Intel stated that it could not reasonably estimate potential losses in the McAfee shareholder litigation, while warning that adverse outcomes in legal matters could be material.
- Other commitments: Contractual obligations totaled $55.576B, including $42.020B of long-term debt principal and interest and $7.529B of capital purchase obligations. Intel reported no significant off-balance-sheet arrangements.
Most important facts for investors to verify
- Whether growth in Data Center and IoT can offset weaker PC unit demand and the continuing decline in memory-segment profitability.
- Whether Intel realizes the projected $1.6B annual restructuring savings on schedule and reallocates them effectively.
- How much of 2016 earnings benefited from the longer depreciation-life estimate, and how that estimate affects comparability with prior periods.
- The actual cash, debt, and financing implications of the planned ISecG divestiture and Altera integration.
- Developments in the European competition appeal and other litigation, and any changes to estimated exposure.
- 2017 numeric guidance and execution on 10nm and 3D XPoint; the filing itself does not provide clear numeric full-year guidance.